Serveur d'exploration sur la grippe en Espagne

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Assessment of two complementary influenza surveillance systems: sentinel primary care influenza-like illness versus severe hospitalized laboratory-confirmed influenza using the moving epidemic method.

Identifieur interne : 000038 ( Main/Exploration ); précédent : 000037; suivant : 000039

Assessment of two complementary influenza surveillance systems: sentinel primary care influenza-like illness versus severe hospitalized laboratory-confirmed influenza using the moving epidemic method.

Auteurs : Núria Torner [Espagne] ; Luca Basile [Espagne] ; Ana Martínez [Espagne] ; Cristina Rius [Espagne] ; Pere Godoy [Espagne] ; Mireia Jané [Espagne] ; Ángela Domínguez [Espagne]

Source :

RBID : pubmed:31409397

Descripteurs français

English descriptors

Abstract

BACKGROUND

Monitoring seasonal influenza epidemics is the corner stone to epidemiological surveillance of acute respiratory virus infections worldwide. This work aims to compare two sentinel surveillance systems within the Daily Acute Respiratory Infection Information System of Catalonia (PIDIRAC), the primary care ILI and Influenza confirmed samples from primary care (PIDIRAC-ILI and PIDIRAC-FLU) and the severe hospitalized laboratory confirmed influenza system (SHLCI), in regard to how they behave in the forecasting of epidemic onset and severity allowing for healthcare preparedness.

METHODS

Epidemiological study carried out during seven influenza seasons (2010-2017) in Catalonia, with data from influenza sentinel surveillance of primary care physicians reporting ILI along with laboratory confirmation of influenza from systematic sampling of ILI cases and 12 hospitals that provided data on severe hospitalized cases with laboratory-confirmed influenza (SHLCI-FLU). Epidemic thresholds for ILI and SHLCI-FLU (overall) as well as influenza A (SHLCI-FLUA) and influenza B (SHLCI-FLUB) incidence rates were assessed by the Moving Epidemics Method.

RESULTS

Epidemic thresholds for primary care sentinel surveillance influenza-like illness (PIDIRAC-ILI) incidence rates ranged from 83.65 to 503.92 per 100.000 h. Paired incidence rate curves for SHLCI -FLU / PIDIRAC-ILI and SHLCI-FLUA/ PIDIRAC-FLUA showed best correlation index' (0.805 and 0.724 respectively). Assessing delay in reaching epidemic level, PIDIRAC-ILI source forecasts an average of 1.6 weeks before the rest of sources paired. Differences are higher when SHLCI cases are paired to PIDIRAC-ILI and PIDIRAC-FLUB although statistical significance was observed only for SHLCI-FLU/PIDIRAC-ILI (p-value Wilcoxon test = 0.039).

CONCLUSIONS

The combined ILI and confirmed influenza from primary care along with the severe hospitalized laboratory confirmed influenza data from PIDIRAC sentinel surveillance system provides timely and accurate syndromic and virological surveillance of influenza from the community level to hospitalization of severe cases.


DOI: 10.1186/s12889-019-7414-9
PubMed: 31409397
PubMed Central: PMC6691547


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Assessment of two complementary influenza surveillance systems: sentinel primary care influenza-like illness versus severe hospitalized laboratory-confirmed influenza using the moving epidemic method.</title>
<author>
<name sortKey="Torner, Nuria" sort="Torner, Nuria" uniqKey="Torner N" first="Núria" last="Torner">Núria Torner</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia, Spain. nuria.torner@gencat.cat.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia</wicri:regionArea>
<wicri:noRegion>Catalonia</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain. nuria.torner@gencat.cat.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Medicine Department, University of Barcelona, Barcelona, Spain. nuria.torner@gencat.cat.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Medicine Department, University of Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Basile, Luca" sort="Basile, Luca" uniqKey="Basile L" first="Luca" last="Basile">Luca Basile</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia</wicri:regionArea>
<wicri:noRegion>Catalonia</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Martinez, Ana" sort="Martinez, Ana" uniqKey="Martinez A" first="Ana" last="Martínez">Ana Martínez</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia</wicri:regionArea>
<wicri:noRegion>Catalonia</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rius, Cristina" sort="Rius, Cristina" uniqKey="Rius C" first="Cristina" last="Rius">Cristina Rius</name>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Public Health Agency of Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Public Health Agency of Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Godoy, Pere" sort="Godoy, Pere" uniqKey="Godoy P" first="Pere" last="Godoy">Pere Godoy</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia</wicri:regionArea>
<wicri:noRegion>Catalonia</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jane, Mireia" sort="Jane, Mireia" uniqKey="Jane M" first="Mireia" last="Jané">Mireia Jané</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia</wicri:regionArea>
<wicri:noRegion>Catalonia</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Ángela" last="Domínguez">Ángela Domínguez</name>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Medicine Department, University of Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Medicine Department, University of Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31409397</idno>
<idno type="pmid">31409397</idno>
<idno type="doi">10.1186/s12889-019-7414-9</idno>
<idno type="pmc">PMC6691547</idno>
<idno type="wicri:Area/Main/Corpus">00007</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00007</idno>
<idno type="wicri:Area/Main/Curation">000007</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000007</idno>
<idno type="wicri:Area/Main/Exploration">000007</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Assessment of two complementary influenza surveillance systems: sentinel primary care influenza-like illness versus severe hospitalized laboratory-confirmed influenza using the moving epidemic method.</title>
<author>
<name sortKey="Torner, Nuria" sort="Torner, Nuria" uniqKey="Torner N" first="Núria" last="Torner">Núria Torner</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia, Spain. nuria.torner@gencat.cat.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia</wicri:regionArea>
<wicri:noRegion>Catalonia</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain. nuria.torner@gencat.cat.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Medicine Department, University of Barcelona, Barcelona, Spain. nuria.torner@gencat.cat.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Medicine Department, University of Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Basile, Luca" sort="Basile, Luca" uniqKey="Basile L" first="Luca" last="Basile">Luca Basile</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia</wicri:regionArea>
<wicri:noRegion>Catalonia</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Martinez, Ana" sort="Martinez, Ana" uniqKey="Martinez A" first="Ana" last="Martínez">Ana Martínez</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia</wicri:regionArea>
<wicri:noRegion>Catalonia</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rius, Cristina" sort="Rius, Cristina" uniqKey="Rius C" first="Cristina" last="Rius">Cristina Rius</name>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Public Health Agency of Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Public Health Agency of Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Godoy, Pere" sort="Godoy, Pere" uniqKey="Godoy P" first="Pere" last="Godoy">Pere Godoy</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia</wicri:regionArea>
<wicri:noRegion>Catalonia</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Jane, Mireia" sort="Jane, Mireia" uniqKey="Jane M" first="Mireia" last="Jané">Mireia Jané</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia</wicri:regionArea>
<wicri:noRegion>Catalonia</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Ángela" last="Domínguez">Ángela Domínguez</name>
<affiliation wicri:level="3">
<nlm:affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Medicine Department, University of Barcelona, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Medicine Department, University of Barcelona, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">BMC public health</title>
<idno type="eISSN">1471-2458</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Epidemics (MeSH)</term>
<term>Hospitalization (statistics & numerical data)</term>
<term>Humans (MeSH)</term>
<term>Influenza A virus (isolation & purification)</term>
<term>Influenza B virus (isolation & purification)</term>
<term>Influenza, Human (diagnosis)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (therapy)</term>
<term>Laboratories, Hospital (MeSH)</term>
<term>Primary Health Care (MeSH)</term>
<term>Reproducibility of Results (MeSH)</term>
<term>Seasons (MeSH)</term>
<term>Sentinel Surveillance (MeSH)</term>
<term>Severity of Illness Index (MeSH)</term>
<term>Spain (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Espagne (épidémiologie)</term>
<term>Grippe humaine (diagnostic)</term>
<term>Grippe humaine (thérapie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Hospitalisation (statistiques et données numériques)</term>
<term>Humains (MeSH)</term>
<term>Indice de gravité de la maladie (MeSH)</term>
<term>Laboratoires hospitaliers (MeSH)</term>
<term>Reproductibilité des résultats (MeSH)</term>
<term>Saisons (MeSH)</term>
<term>Soins de santé primaires (MeSH)</term>
<term>Surveillance sentinelle (MeSH)</term>
<term>Virus de la grippe A (isolement et purification)</term>
<term>Virus influenza B (isolement et purification)</term>
<term>Épidémies (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Influenza A virus</term>
<term>Influenza B virus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Virus de la grippe A</term>
<term>Virus influenza B</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en">
<term>Hospitalization</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr">
<term>Hospitalisation</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr">
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Espagne</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Epidemics</term>
<term>Humans</term>
<term>Laboratories, Hospital</term>
<term>Primary Health Care</term>
<term>Reproducibility of Results</term>
<term>Seasons</term>
<term>Sentinel Surveillance</term>
<term>Severity of Illness Index</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Humains</term>
<term>Indice de gravité de la maladie</term>
<term>Laboratoires hospitaliers</term>
<term>Reproductibilité des résultats</term>
<term>Saisons</term>
<term>Soins de santé primaires</term>
<term>Surveillance sentinelle</term>
<term>Épidémies</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>Monitoring seasonal influenza epidemics is the corner stone to epidemiological surveillance of acute respiratory virus infections worldwide. This work aims to compare two sentinel surveillance systems within the Daily Acute Respiratory Infection Information System of Catalonia (PIDIRAC), the primary care ILI and Influenza confirmed samples from primary care (PIDIRAC-ILI and PIDIRAC-FLU) and the severe hospitalized laboratory confirmed influenza system (SHLCI), in regard to how they behave in the forecasting of epidemic onset and severity allowing for healthcare preparedness.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS</b>
</p>
<p>Epidemiological study carried out during seven influenza seasons (2010-2017) in Catalonia, with data from influenza sentinel surveillance of primary care physicians reporting ILI along with laboratory confirmation of influenza from systematic sampling of ILI cases and 12 hospitals that provided data on severe hospitalized cases with laboratory-confirmed influenza (SHLCI-FLU). Epidemic thresholds for ILI and SHLCI-FLU (overall) as well as influenza A (SHLCI-FLUA) and influenza B (SHLCI-FLUB) incidence rates were assessed by the Moving Epidemics Method.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>Epidemic thresholds for primary care sentinel surveillance influenza-like illness (PIDIRAC-ILI) incidence rates ranged from 83.65 to 503.92 per 100.000 h. Paired incidence rate curves for SHLCI -FLU / PIDIRAC-ILI and SHLCI-FLUA/ PIDIRAC-FLUA showed best correlation index' (0.805 and 0.724 respectively). Assessing delay in reaching epidemic level, PIDIRAC-ILI source forecasts an average of 1.6 weeks before the rest of sources paired. Differences are higher when SHLCI cases are paired to PIDIRAC-ILI and PIDIRAC-FLUB although statistical significance was observed only for SHLCI-FLU/PIDIRAC-ILI (p-value Wilcoxon test = 0.039).</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSIONS</b>
</p>
<p>The combined ILI and confirmed influenza from primary care along with the severe hospitalized laboratory confirmed influenza data from PIDIRAC sentinel surveillance system provides timely and accurate syndromic and virological surveillance of influenza from the community level to hospitalization of severe cases.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">
<PMID Version="1">31409397</PMID>
<DateCompleted>
<Year>2019</Year>
<Month>11</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>02</Month>
<Day>25</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">1471-2458</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>19</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2019</Year>
<Month>Aug</Month>
<Day>13</Day>
</PubDate>
</JournalIssue>
<Title>BMC public health</Title>
<ISOAbbreviation>BMC Public Health</ISOAbbreviation>
</Journal>
<ArticleTitle>Assessment of two complementary influenza surveillance systems: sentinel primary care influenza-like illness versus severe hospitalized laboratory-confirmed influenza using the moving epidemic method.</ArticleTitle>
<Pagination>
<MedlinePgn>1089</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-019-7414-9</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Monitoring seasonal influenza epidemics is the corner stone to epidemiological surveillance of acute respiratory virus infections worldwide. This work aims to compare two sentinel surveillance systems within the Daily Acute Respiratory Infection Information System of Catalonia (PIDIRAC), the primary care ILI and Influenza confirmed samples from primary care (PIDIRAC-ILI and PIDIRAC-FLU) and the severe hospitalized laboratory confirmed influenza system (SHLCI), in regard to how they behave in the forecasting of epidemic onset and severity allowing for healthcare preparedness.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Epidemiological study carried out during seven influenza seasons (2010-2017) in Catalonia, with data from influenza sentinel surveillance of primary care physicians reporting ILI along with laboratory confirmation of influenza from systematic sampling of ILI cases and 12 hospitals that provided data on severe hospitalized cases with laboratory-confirmed influenza (SHLCI-FLU). Epidemic thresholds for ILI and SHLCI-FLU (overall) as well as influenza A (SHLCI-FLUA) and influenza B (SHLCI-FLUB) incidence rates were assessed by the Moving Epidemics Method.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Epidemic thresholds for primary care sentinel surveillance influenza-like illness (PIDIRAC-ILI) incidence rates ranged from 83.65 to 503.92 per 100.000 h. Paired incidence rate curves for SHLCI -FLU / PIDIRAC-ILI and SHLCI-FLUA/ PIDIRAC-FLUA showed best correlation index' (0.805 and 0.724 respectively). Assessing delay in reaching epidemic level, PIDIRAC-ILI source forecasts an average of 1.6 weeks before the rest of sources paired. Differences are higher when SHLCI cases are paired to PIDIRAC-ILI and PIDIRAC-FLUB although statistical significance was observed only for SHLCI-FLU/PIDIRAC-ILI (p-value Wilcoxon test = 0.039).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The combined ILI and confirmed influenza from primary care along with the severe hospitalized laboratory confirmed influenza data from PIDIRAC sentinel surveillance system provides timely and accurate syndromic and virological surveillance of influenza from the community level to hospitalization of severe cases.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Torner</LastName>
<ForeName>Núria</ForeName>
<Initials>N</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-0143-5295</Identifier>
<AffiliationInfo>
<Affiliation>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia, Spain. nuria.torner@gencat.cat.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain. nuria.torner@gencat.cat.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Medicine Department, University of Barcelona, Barcelona, Spain. nuria.torner@gencat.cat.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Basile</LastName>
<ForeName>Luca</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Martínez</LastName>
<ForeName>Ana</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rius</LastName>
<ForeName>Cristina</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Public Health Agency of Barcelona, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Godoy</LastName>
<ForeName>Pere</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jané</LastName>
<ForeName>Mireia</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Health, Public Health Agency of Catalonia, Generalitat of Catalonia, Salvany Building, Roc Boronat 81-95, 08005, Barcelona, Catalonia, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Domínguez</LastName>
<ForeName>Ángela</ForeName>
<Initials>Á</Initials>
<AffiliationInfo>
<Affiliation>CIBER Epidemiología y Salud Pública (CIBERESP) Institute Carlos III, Madrid, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Medicine Department, University of Barcelona, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>Working Group on PIDIRAC Sentinel Surveillance of Catalonia</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>2017/SGR 1342</GrantID>
<Agency>Grants for University Research (AGAUR)</Agency>
<Country></Country>
</Grant>
<Grant>
<GrantID>Prevention and Control of Transmissible Diseases (PREVICET)</GrantID>
<Agency>CIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III</Agency>
<Country></Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2019</Year>
<Month>08</Month>
<Day>13</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>BMC Public Health</MedlineTA>
<NlmUniqueID>100968562</NlmUniqueID>
<ISSNLinking>1471-2458</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D058872" MajorTopicYN="Y">Epidemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009981" MajorTopicYN="N">Influenza B virus</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007755" MajorTopicYN="N">Laboratories, Hospital</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011320" MajorTopicYN="Y">Primary Health Care</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018571" MajorTopicYN="Y">Sentinel Surveillance</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Epidemic</Keyword>
<Keyword MajorTopicYN="N">Hospitalization</Keyword>
<Keyword MajorTopicYN="N">Influenza</Keyword>
<Keyword MajorTopicYN="N">Influenza like illness</Keyword>
<Keyword MajorTopicYN="N">Primary health care</Keyword>
<Keyword MajorTopicYN="N">Sentinel surveillance</Keyword>
<Keyword MajorTopicYN="N">Threshold</Keyword>
</KeywordList>
<InvestigatorList>
<Investigator ValidYN="Y">
<LastName>Aizpurua</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Alonso</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Azemar</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Aizpurua</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ardaya</LastName>
<ForeName>P M</ForeName>
<Initials>PM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Basas</LastName>
<ForeName>M D</ForeName>
<Initials>MD</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Batalla</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Biendicho</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bonet</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Callado</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Campos</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Casanovas</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ciurana</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Clapes</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Cots</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>De la Rica</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Domingo</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Elizalde</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Escapa</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fajardo</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fau</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fernandez</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fernandez</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ferrer</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Forcada</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Fos</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gadea</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Garcia</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Garcia</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gatius</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gelado</LastName>
<ForeName>M J</ForeName>
<Initials>MJ</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Grau</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Grivé</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Guzman</LastName>
<ForeName>M C</ForeName>
<Initials>MC</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hernández</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Jimenez</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Juscafresa</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>LLussa</LastName>
<ForeName>A M</ForeName>
<Initials>AM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>López</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Kristensen</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Macià</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mainou</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Marco</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Martínez</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Martínez</LastName>
<ForeName>J G</ForeName>
<Initials>JG</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Marulanda</LastName>
<ForeName>K V</ForeName>
<Initials>KV</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Masa</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Moncosí</LastName>
<ForeName>X</ForeName>
<Initials>X</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Naranjo</LastName>
<ForeName>M A</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Navarro</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ortolà</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>París</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pérez</LastName>
<ForeName>M M</ForeName>
<Initials>MM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pozo</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pujol</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ribatallada</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ruiz</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sabaté</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sanchez</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sarrà</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tarragó</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Teixidó</LastName>
<ForeName>A M</ForeName>
<Initials>AM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Torres</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Valén</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Van Esso</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Van Tarjcwick</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vink Schoenholzer</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Zabala</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Marcos</LastName>
<ForeName>M A</ForeName>
<Initials>MA</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mosquera</LastName>
<ForeName>M D M</ForeName>
<Initials>MDM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>de Molina</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rubio</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Isanta</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Anton</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pumarola</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Vilella</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Gorrindo</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Espejo</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Andrés</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Barcenilla</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Navarro</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Barrabeig</LastName>
<ForeName>I</ForeName>
<Initials>I</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Pou</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Alvarez</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Plasencia</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rebull</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Sala</LastName>
<ForeName>M R</ForeName>
<Initials>MR</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Riera</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Camps</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Follia</LastName>
<ForeName>N</ForeName>
<Initials>N</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Oller</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Godoy</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Bach</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Rius</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Hernández</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Perez</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Torra</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Carol</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Minguell</LastName>
<ForeName>S</ForeName>
<Initials>S</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Marce</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Garcia-Pardo</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Olona</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Alvarez</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ramon</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mòdol</LastName>
<ForeName>J M</ForeName>
<Initials>JM</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Mena</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Campins</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Massuet</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Tora</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ferràs</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Investigator>
<Investigator ValidYN="Y">
<LastName>Ferrús</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Investigator>
</InvestigatorList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2018</Year>
<Month>11</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2019</Year>
<Month>07</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2019</Year>
<Month>8</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2019</Year>
<Month>8</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>11</Month>
<Day>9</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">31409397</ArticleId>
<ArticleId IdType="doi">10.1186/s12889-019-7414-9</ArticleId>
<ArticleId IdType="pii">10.1186/s12889-019-7414-9</ArticleId>
<ArticleId IdType="pmc">PMC6691547</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Clin Virol. 2003 Jul;27(2):170-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12829039</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Influenza Other Respir Viruses. 2009 Jan;3(1):37-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19453440</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2011 Oct;17(10):1963-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22000386</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2011 Dec 3;378(9807):1917-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22078723</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Influenza Other Respir Viruses. 2013 Jan;7(1):74-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22443191</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Commun Dis Intell Q Rep. 2011 Dec;35(4):288-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22624489</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Influenza Other Respir Viruses. 2013 Jul;7(4):546-58</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22897919</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Infect Control Hosp Epidemiol. 2012 Oct;33(10):1064-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22961034</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2013 Sep 22;13:441</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24053661</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>MMWR Morb Mortal Wkly Rep. 2014 Feb 21;63(7):143-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24553197</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2014 Jul 10;14:381</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25011679</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Epidemiol Infect. 2015 Jan;143(1):1-12</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25023603</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2014 Oct 7;32(44):5816-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25173483</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Influenza Other Respir Viruses. 2015 Sep;9(5):234-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26031655</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2015 Sep;21(9):1543-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26291121</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2017 Jan 11;12(1):e0169801</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28076411</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Commun Dis Intell Q Rep. 2016 Sep 30;40(3):E351-E355</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28278409</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMC Infect Dis. 2017 Dec 16;17(1):772</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29246199</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2018 Mar 31;391(10127):1285-1300</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29248255</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Vaccine. 2018 Jan 25;36(4):442-452</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29287683</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2018 Feb 15;14(2):e1006770</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29447284</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2018 Mar;23(11):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29560854</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2019 Mar;24(12):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30914080</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Espagne</li>
</country>
<region>
<li>Catalogne</li>
<li>Communauté de Madrid</li>
</region>
<settlement>
<li>Barcelone</li>
<li>Madrid</li>
</settlement>
</list>
<tree>
<country name="Espagne">
<noRegion>
<name sortKey="Torner, Nuria" sort="Torner, Nuria" uniqKey="Torner N" first="Núria" last="Torner">Núria Torner</name>
</noRegion>
<name sortKey="Basile, Luca" sort="Basile, Luca" uniqKey="Basile L" first="Luca" last="Basile">Luca Basile</name>
<name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Ángela" last="Domínguez">Ángela Domínguez</name>
<name sortKey="Dominguez, Angela" sort="Dominguez, Angela" uniqKey="Dominguez A" first="Ángela" last="Domínguez">Ángela Domínguez</name>
<name sortKey="Godoy, Pere" sort="Godoy, Pere" uniqKey="Godoy P" first="Pere" last="Godoy">Pere Godoy</name>
<name sortKey="Godoy, Pere" sort="Godoy, Pere" uniqKey="Godoy P" first="Pere" last="Godoy">Pere Godoy</name>
<name sortKey="Jane, Mireia" sort="Jane, Mireia" uniqKey="Jane M" first="Mireia" last="Jané">Mireia Jané</name>
<name sortKey="Jane, Mireia" sort="Jane, Mireia" uniqKey="Jane M" first="Mireia" last="Jané">Mireia Jané</name>
<name sortKey="Martinez, Ana" sort="Martinez, Ana" uniqKey="Martinez A" first="Ana" last="Martínez">Ana Martínez</name>
<name sortKey="Martinez, Ana" sort="Martinez, Ana" uniqKey="Martinez A" first="Ana" last="Martínez">Ana Martínez</name>
<name sortKey="Rius, Cristina" sort="Rius, Cristina" uniqKey="Rius C" first="Cristina" last="Rius">Cristina Rius</name>
<name sortKey="Rius, Cristina" sort="Rius, Cristina" uniqKey="Rius C" first="Cristina" last="Rius">Cristina Rius</name>
<name sortKey="Torner, Nuria" sort="Torner, Nuria" uniqKey="Torner N" first="Núria" last="Torner">Núria Torner</name>
<name sortKey="Torner, Nuria" sort="Torner, Nuria" uniqKey="Torner N" first="Núria" last="Torner">Núria Torner</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000038 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000038 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeEspagneV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:31409397
   |texte=   Assessment of two complementary influenza surveillance systems: sentinel primary care influenza-like illness versus severe hospitalized laboratory-confirmed influenza using the moving epidemic method.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:31409397" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeEspagneV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Fri Sep 25 11:01:38 2020. Site generation: Sat Feb 13 17:38:04 2021